Navigation Links
Lancaster Laboratories -- First Lab to be A2LA Accredited for 30 Consecutive Years
Date:11/3/2009

Lancaster Laboratories was the first organization to become accredited by the American Association for Laboratory Accreditation (A2LA) and was assigned certificate number 1.01 thirty years ago.

(Vocus) November 3, 2009 -- Lancaster Laboratories was the first organization to become accredited by the American Association for Laboratory Accreditation (A2LA) and was assigned certificate number 1.01 thirty years ago.

Achieving this milestone is a testament to the importance the laboratory owners and staff place on quality, competence and producing reliable data for their clients. “Sustaining this level of quality and service for such a long time is no easy feat. Everyone at Lancaster Laboratories should be very proud.” said Pete Unger, President of A2LA.

Lancaster, with annual sales of more than $95 million, is one of the largest commercial testing laboratories in the world, specializing in the environmental, food, pharmaceutical and biopharmaceutical sciences. Founded in 1961, it has more than 900 employees worldwide and laboratories in Pennsylvania and Ireland.

“We're one of the largest contract laboratories in the country,” said J. Wilson Hershey, Ph.D., Lancaster’s President. “We provide comprehensive analytical and regulatory compliance services in client facilities and our own labs.”

A2LA is a nonprofit, non-governmental, public service, membership society, whose stated mission is “to provide comprehensive accreditation services for laboratories, inspection bodies, proficiency testing providers, and reference material producers.”

Services are available to any type of laboratory or inspection body, product certification body, reference material provider, and proficiency testing provider, whether governmental or private. It is the largest multi-discipline accreditation body in the United States.

Contact Information:
Philip Smith
A2LA Contact
American Association for Laboratory Accreditation (A2LA)
Phone: 301 644 3204
Web: www.A2LA.org

###

Read the full story at http://www.prweb.com/releases/Lancaster_Laboratories/A2LA/prweb3140464.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Codexis Appoints Singapore Laboratories Managing Director
2. ARUP Laboratories and Premier Extend Contract for Reference Laboratory Testing Services
3. Forest Laboratories Announces Federal Appeals Court Upholds Lexapro(R) Patent Decision
4. Microbia and Forest Laboratories Announce Linaclotide Co-Development and Co-Marketing Collaboration
5. Stiefel Laboratories Appoints Two New Members to Board of Directors
6. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Methimazole Tablets USP, 5 mg and 10 mg
7. ARUP Laboratories Releases ARUP Consult(R) 2.0
8. Forest Laboratories Lexapro and Generics-Dominated Fluoxetine Lead First-Line Therapy in the Treatment for Major Depression
9. Carrington Laboratories Common Stock Now Trading on the OTC Bulletin Board: CARN.OB
10. Free White Paper Helps Biotech Laboratories Maintain a High Level of Infection Control
11. Romark Laboratories Names Emmet B. Keeffe, M.D. Vice President and Chief Medical Officer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Lancaster Laboratories -- First Lab to be A2LA Accredited for 30 Consecutive Years
(Date:3/23/2017)... 23, 2017 In today,s pre-market ... in the Biotech industry: Sangamo Therapeutics Inc. (NASDAQ: SGMO), ... MKT: SYN), and Regulus Therapeutics Inc. (NASDAQ: ... Credit Suisse upgraded its rating on Pharmaceuticals/Biotechnology to "Overweight" from "Market Weight." ... report at: ...
(Date:3/22/2017)... , March 22, 2017  UBM and ... to announce their extended partnership and the third ... headlined by the 21 st Annual MassMEDIC ... taking place May 3-4, 2017. ... Technology Association (ADVAMED) President and CEO, Scott ...
(Date:3/22/2017)... , March 22, 2017 MarketNewsUpdates.com ... ... cancer conditions are being pressured as of late due to ... cancer pain management has a dramatic impact on patient,s quality ... and development activities for identifying new forms of opioid formulations ...
(Date:3/22/2017)... ... March 21, 2017 , ... Okyanos Cell Therapy has announced Tallahassee, FL ... live events series, “Stem Cell Therapy: The Next Phase in the Evolution of Medicine.” ... Stem Cell Research and Therapy Act, Okyanos maintains a mission to help “no-option” ...
Breaking Biology Technology:
(Date:2/16/2017)... 2017  Genos, a community for personal genetic ... received Laboratory Accreditation from the College of American ... laboratories that meet stringent requirements around quality, accuracy ... "Genos is committed to maintaining the ... honored to be receiving CAP accreditation," said ...
(Date:2/10/2017)... Feb 10, 2017 Research and ... "Personalized Medicine - Scientific and Commercial Aspects" to ... ... Diagnosis is integrated with therapy for selection of treatment as ... detection and prevention of disease in modern medicine. Biochip/microarray technologies ...
(Date:2/8/2017)... 2017 Report Highlights ... The global synthetic-biology market reached nearly ... 2021, growing at a compound annual growth rate (CAGR) of ... the global markets for synthetic biology. - Analyses of global ... projections of compound annual growth rates (CAGRs) through 2021. - ...
Breaking Biology News(10 mins):